Filing Details

Accession Number:
0001144204-12-067465
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-11 17:23:18
Reporting Period:
2012-12-07
Filing Date:
2012-12-11
Accepted Time:
2012-12-11 17:23:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
768408 Cyanotech Corp CYAN Medicinal Chemicals & Botanical Products (2833) 911206026
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201156 / A Michael Davis 73-4460 Queen Kaahumanu Hwy #102
Kailua-Kona HI 96740
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Cyanotech Corporation Common Stock Acquisiton 2012-12-07 17,500 $5.01 325,150 No 4 P Indirect By self as trustee of the Michael Arlen Davis Revocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By self as trustee of the Michael Arlen Davis Revocable Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Cyanotech Corporation Common Stock 48,013 Direct
Cyanotech Corporation Common Stock 750 Indirect By self as co-trustee of the Michael Davis 1993 Family Trust
Cyanotech Corporation Common Stock 31,250 Indirect By spouse
Cyanotech Corporation Common Stock 150,000 Indirect By self as co-trustee of trusts for the benefit of Mr. Davis' children
Cyanotech Corporation Common Stock 480,769 Indirect By self as co-trustee of the Michael Arlen Davis Charitable Lead Annuity Trust
Cyanotech Corporation Common Stock 50,000 Indirect By self as UTMA custodian for daughters
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.60 to $5.25, inclusive. The reporting person undertakes to provide to Cyanotech Corporation, any security holder of Cyanotech Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. Excludes 307,650 shares previously owned directly which were contributed to a revocable trust on October 10, 2012.